Clinical Trials Browser

Phase 1/2 × Active not recruiting × Astrocytoma × Clear all

NCT01089101 2026-03-18

Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma

Phase 1/2 Active not recruiting

Astrocytoma, Neurofibromatosis 1